Form D · Other Technology
BiOMOTUM, Inc.
Portland, OR · CIK 0001831281
Offering snapshot reported Mar 31, 2022 · SEC filing
- Reported sold
- $200K Offering amount: $1.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2022 | Initial | $200,000 | No comparison | 2 | SEC filing |
| Nov 13, 2020 | Amendment | $660,000 | $80,000vs Nov 9, 2020 | 3 | SEC filing |
| Nov 9, 2020 | Initial | $580,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-439763
Source: Form D, filed Mar 31, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Raymond C. Browning | Director, Executive |
| Zachary L. Lerner | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4885 Ne Going Street
Portland, OR, 97218
Portland, OR, 97218